SCHEMBL16888262

SCHEMBL16888262

COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(C)cc6o5)ccc4OC)c3o2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.76
USP2 O75604 2/20 0.76
TP53 P04637 2/20 0.76
MAPT P10636 2/20 0.76
KMT2A Q03164 2/20 0.76
KDM4E B2RXH2 1/20 0.76
HPGD P15428 1/20 0.76
ALOX15 P16050 1/20 0.76
HBB P68871 1/20 0.76
HSD17B10 Q99714 1/20 0.76
ADORA3 P0DMS8 1/20 0.70
APP P05067 5/20 0.64
MMP3 P08254 2/20 0.60
MMP9 P14780 2/20 0.60
MAOB P27338 2/20 0.59
CYP19A1 P11511 1/20 0.59
IP6K2 Q9UHH9 3/20 0.57
FLT3 P36888 3/20 0.57
CYP1B1 Q16678 3/20 0.57
CYP1A1 P04798 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sciadopitisin SCHEMBL1158050 0.93 MAPT (0.86) MEN1USP2TP53MAPTKMT2A
Sciadopitisin SCHEMBL30996894 0.93 MAPT (0.86) MEN1USP2TP53MAPTKMT2A
Isoginkgetin SCHEMBL30293900 0.92 MEN1 (0.80) MEN1USP2TP53MAPTKMT2A
Isoginkgetin SCHEMBL22459983 0.92 MEN1 (0.80) MEN1USP2TP53MAPTKMT2A
Ginkgetin SCHEMBL31303838 0.90 MAPT (0.86) MEN1USP2TP53MAPTKMT2A
Ginkgetin SCHEMBL888410 0.90 MAPT (0.86) MEN1USP2TP53MAPTKMT2A
Ginkgetin SCHEMBL30612275 0.90 MAPT (0.86) MEN1USP2TP53MAPTKMT2A
SCHEMBL17166015 0.88 MEN1 (0.74) MEN1USP2TP53MAPTKMT2A
SCHEMBL22459584 0.88 MAPT (0.77) MEN1USP2TP53MAPTKMT2A
Kayaflavone SCHEMBL30646162 0.86 MEN1 (0.71) MEN1USP2TP53MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150190411-A1 ACTIVATION OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS AGAINST DNA DAMAGE AND INCREASES NEURONAL SURVIVAL MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150190411-A1 ACTIVATION OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS AGAINST DNA DAMAGE AND INCREASES NEURONAL SURVIVAL GRIK5, HDAC11, GRIK1 MEN1 3160/4885USP2 4546/4885TP53 1633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.